Change in Bone Mineral Density and Role of Vitamin D and Calcium Supplementation During Treatment of First Episode Nephrotic Syndrome.

about

Change in Bone Mineral Density and Role of Vitamin D and Calcium Supplementation During Treatment of First Episode Nephrotic Syndrome.

Item

http://www.wikidata.org/entity/Q47106939

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Change in Bone Mineral Density ...... st Episode Nephrotic Syndrome.

@en

Change in Bone Mineral Density ...... st Episode Nephrotic Syndrome.

@nl

type

Item

label

Change in Bone Mineral Density ...... st Episode Nephrotic Syndrome.

@en

Change in Bone Mineral Density ...... st Episode Nephrotic Syndrome.

@nl

prefLabel

Change in Bone Mineral Density ...... st Episode Nephrotic Syndrome.

@en

Change in Bone Mineral Density ...... st Episode Nephrotic Syndrome.

@nl

P1476

Change in Bone Mineral Density ...... st Episode Nephrotic Syndrome.

@en

P2093

Bhaskar C Kabi

http://www.w3.org/2001/XMLSchema#string

Kailash Chandra Aggrawal

http://www.w3.org/2001/XMLSchema#string

Pradeep Kumar Debata

http://www.w3.org/2001/XMLSchema#string

Seema Patel

http://www.w3.org/2001/XMLSchema#string

Shobha Sharma

http://www.w3.org/2001/XMLSchema#string

Virendra Kumar Yadav

http://www.w3.org/2001/XMLSchema#string

P2860

Bone mineral density in children with steroid-sensitive nephrotic syndrome.

Revised guidelines for management of steroid-sensitive nephrotic syndrome.

Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy.

Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome.

Children and the risk of fractures caused by oral corticosteroids.

Bone mass in healthy children: measurement with quantitative DXA.

Vitamin D status and bone density in steroid-treated children with glomerulopathies: effect of cholecalciferol and calcium supplementation.

Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.

Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.

[Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].

P304

SC18-SC21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7860/JCDR/2017/27030.10657

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207799

http://www.w3.org/2001/XMLSchema#string

P921

vitamin D

P932

5713821

http://www.w3.org/2001/XMLSchema#string